-+ 0.00%
-+ 0.00%
-+ 0.00%

Does Antivirus Launch Change The Bull Case For Ziff Davis Stock?

Simply Wall St·10/09/2026 10:39:43
Listen to the news
  • IPVanish, a Ziff Davis subsidiary, has rolled out a next generation antivirus for Windows and macOS that combines VPN privacy with device security. The service uses the VIPRE engine to add anti ransomware protections, malware scanning, and real time threat detection, alongside a revamped three tier subscription lineup.
  • The integration of VPN and antivirus inside a single IPVanish app, along with refreshed pricing tiers, signals Ziff Davis pushing deeper into bundled cybersecurity subscriptions that can influence customer retention, cross sell potential, and long term margins in its security portfolio.
  • We will now look at how Ziff Davis’s investment narrative could shift as IPVanish combines VPN and antivirus in one subscription.

Scan beyond Ziff Davis to assess how other cybersecurity focused businesses are repositioning for bundled protection by reviewing the hand picked 31 resilient stocks with low risk scores in this space.

Ziff Davis Investment Narrative Recap

To own Ziff Davis, you need to believe the shift toward subscriptions in areas like Cybersecurity and Martech can offset pressure in search driven media and advertising. The key near term swing factor is whether management can stabilize revenue that recently fell 2.7% year over year while working back from an operating loss of US$44.7 million.

The biggest operational risk is that AI overviews and weaker Tech & Shopping demand keep eroding high margin affiliate and programmatic income. IPVanish’s bundled VPN and antivirus launch is directionally helpful for subscription mix, but on its own it is unlikely to fully change the short term earnings picture.

Among recent moves, the US$1.2b Connectivity sale and the roughly US$1.6b balance sheet capacity tied to it matter most, alongside the IPVanish launch. That capital gives Ziff Davis room to keep reshaping the portfolio while search exposed segments face structural headwinds from AI driven query changes.

For you as an investor, the combination of active asset monetization, sizable buybacks that retired about 4.5 million shares in 2026, and new subscription products like IPVanish Antivirus creates multiple execution levers. The flip side is clear: if reinvestment and acquisitions disappoint or insider selling persists, the thesis around value and recovery gets much harder to support.

Ziff Davis' current analyst narrative points to revenues of US$1.2b and earnings of US$34.8 million by 2029, from a base of earnings today that reflect a loss of US$29.7 million. That profile assumes revenue will decline 7.2% per year and that earnings would need to swing by about US$64.5 million from the current loss to the 2029 consensus profit.

Uncover how Ziff Davis' fair value indicates a 14% potential upside to its current price, which could narrow quickly if sentiment turns.

NasdaqGS:ZD 1-Year Stock Price Chart
NasdaqGS:ZD 1-Year Stock Price Chart

Exploring Other Perspectives

One alternate view focuses on ad pressure rather than Ziff Davis’s cybersecurity push. The most cautious analysts were already assuming revenue would decline about 6.7% a year and only reach US$1.2b with earnings of US$52.2 million by 2029. You can treat the IPVanish launch as a fresh test of those more pessimistic expectations.

Explore another Ziff Davis fair value estimate, including one that suggests it could be worth just $63.67.

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider relying on your own analysis and judgment.

Looking For More Investment Ideas Beyond Ziff Davis?

Once you have an initial view on Ziff Davis, it can help to compare the opportunity set with other businesses that share some of the same qualities you care about, whether that is value, balance sheet strength, or steady income.

  • If capital protection sits high on your priority list, scan through a curated set of companies with resilient profiles using the 31 resilient stocks with low risk scores.
  • For investors hunting for mispriced opportunities, weigh Ziff Davis against a broader pool of potentially overlooked companies by reviewing the 20 high quality undiscovered gems.
  • Income focused portfolios can widen the search beyond Ziff Davis by comparing yields and payout consistency across the 8 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.